Esomeprazole Magnesium trihydrate (S-Omeprazole magnesium trihydrate) is a proton pump inhibitor (PPI) that is used to reduce gastric acid secretion.

Esomeprazole Magnesium (S-Omeprazole magnesium; Nexium; H 168/68), the magnesium salt of esomeprazole, is S-isomer of omeprazole which is a proton pump inhibitor (PPI) that has been approved for reducing gastric acid secretion (e.g. acid reflux, ulcers).

Dexlansoprazole (formerly known as T168390; TAK390; Kapidex; Dexilant, R-Lansoprazole and TAK-390MR), the dextrorotatory or R-enantiomer of lansoprazole, is a proton pump inhibitor (PPI) formulated to have dual delayed-release properties by employing a novel release formulation that prolongs its absorption.

Tenatoprazole (formerly known as TU-199; TU 199; Ulsacare; Protop) is a prodrug of the proton pump inhibitor (PPI) class with the potential for the treatment of gastroesophageal reflux disease.

This product has been discontinued.

Omeprazole (H-16868; H16868; trade names: Prilosec, Zegerid), approved by the FDA, is available as a prescription and over-the-counter (OTC) drug used as a treatment for frequent heartburn.

Pantoprazole Sodium (BY1023; SKF96022; Protonix) is an anti-ulcer drug that acts as a proton pump inhibitor (PPI) and is used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

Pantoprazole Sodium hydrate (BY1023; SKF96022; Protonix) is an anti-ulcer drug acting as a proton pump inhibitor (PPI) and is used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease.

PF 3716556 (PF3716556; PF-3716556) is a novel, potent and selective P-CAB (potassium-competitive acid blocker: acid pump antagonist) with anti-acid reflux activity.

Esomeprazole magnesium, the magnesium salt of esomeprazole, is a potent proton pump inhibitor (PPI) with potential usefulness in the treatment of gastroesophageal reflux disease-GERD.